X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9556) 9556
Conference Proceeding (32) 32
Dissertation (27) 27
Publication (9) 9
Book Chapter (7) 7
Magazine Article (3) 3
Book / eBook (2) 2
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6607) 6607
a549 cells (6450) 6450
animals (2469) 2469
apoptosis (2367) 2367
cell line, tumor (2281) 2281
lung cancer (1926) 1926
cancer (1766) 1766
lung neoplasms - pathology (1579) 1579
mice (1504) 1504
expression (1337) 1337
biochemistry & molecular biology (1336) 1336
a549 (1247) 1247
lung neoplasms - metabolism (1241) 1241
oncology (1167) 1167
pharmacology & pharmacy (1164) 1164
proteins (1114) 1114
apoptosis - drug effects (1089) 1089
cell survival - drug effects (1073) 1073
cell biology (1047) 1047
female (1029) 1029
lung neoplasms - genetics (1010) 1010
antineoplastic agents - pharmacology (965) 965
cell proliferation - drug effects (964) 964
lung neoplasms - drug therapy (956) 956
cytotoxicity (954) 954
male (930) 930
analysis (894) 894
activation (817) 817
gene expression (805) 805
in-vitro (767) 767
nanoparticles (743) 743
metastasis (728) 728
signal transduction (718) 718
cell proliferation (707) 707
carcinoma, non-small-cell lung - pathology (697) 697
cell line (672) 672
cells (665) 665
inhibition (655) 655
mice, nude (643) 643
oxidative stress (639) 639
tumors (635) 635
proliferation (617) 617
chemotherapy (602) 602
growth (602) 602
toxicity (595) 595
gene expression regulation, neoplastic (591) 591
kinases (586) 586
research (580) 580
cell cycle (571) 571
toxicology (570) 570
carcinoma, non-small-cell lung - metabolism (540) 540
carcinoma, non-small-cell lung - genetics (534) 534
phosphorylation (532) 532
medicine, research & experimental (529) 529
mice, inbred balb c (529) 529
health aspects (525) 525
a549细胞 (519) 519
signal transduction - drug effects (504) 504
dose-response relationship, drug (503) 503
chemistry, medicinal (501) 501
inflammation (488) 488
antineoplastic agents - chemistry (475) 475
hela cells (468) 468
chemistry, multidisciplinary (459) 459
lung cancer, non-small cell (453) 453
adenocarcinoma (445) 445
hek293 cells (445) 445
cancer therapies (437) 437
care and treatment (436) 436
reactive oxygen species - metabolism (429) 429
xenograft model antitumor assays (425) 425
micrornas - genetics (422) 422
protein (416) 416
carcinoma, non-small-cell lung - drug therapy (414) 414
multidisciplinary sciences (414) 414
cell growth (400) 400
mcf-7 cells (396) 396
genetic aspects (392) 392
down-regulation (389) 389
lungs (378) 378
invasion (375) 375
respiratory system (366) 366
pathway (361) 361
cancer cells (357) 357
middle aged (351) 351
rna interference (351) 351
autophagy (347) 347
biophysics (347) 347
non-small cell lung cancer (346) 346
up-regulation (342) 342
development and progression (341) 341
mechanisms (341) 341
migration (340) 340
particle size (326) 326
therapy (323) 323
studies (320) 320
immunology (319) 319
flow cytometry (313) 313
adenocarcinoma - pathology (312) 312
lung-cancer (312) 312
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8547) 8547
Chinese (1117) 1117
Japanese (91) 91
Korean (32) 32
Portuguese (9) 9
French (8) 8
German (4) 4
Russian (3) 3
Spanish (3) 3
Persian (2) 2
Czech (1) 1
Hungarian (1) 1
Italian (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bioimpacts, ISSN 2228-5660, 12/2018, Volume 8, Issue Suppl 1, pp. S1 - S129
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, p. e97070
Proangiogenic enzyme thymidine phosphorylase (TP) is a promising target for anticancer therapy, yet its action in non-small cell lung carcinoma (NSCLC... 
IN-VITRO | IL-8 EXPRESSION | A549 CELLS | MULTIDISCIPLINARY SCIENCES | TUMOR-CELLS | PROLIFERATION | HEME OXYGENASE-1 | CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | PROMOTES ANGIOGENESIS | MOLECULAR-MECHANISMS | Carcinoma, Non-Small-Cell Lung - pathology | Heme Oxygenase-1 - metabolism | Cell Proliferation | Lung Neoplasms - enzymology | Cytokines - metabolism | Carcinoma, Non-Small-Cell Lung - blood supply | Humans | Lung Neoplasms - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Gene Expression Regulation, Neoplastic | Neovascularization, Pathologic | Lung Neoplasms - pathology | Animals | NF-E2-Related Factor 2 - metabolism | Cell Line, Tumor | Female | Mice | Carcinoma, Non-Small-Cell Lung - enzymology | Endothelial Cells - pathology | Thymidine Phosphorylase - metabolism | Cell Movement | Lung Neoplasms - blood supply | Antioxidants | Enzymes | Analysis | Acetylcysteine | Lung cancer, Non-small cell | Gene expression | Vascular endothelial growth factor | Cell proliferation | Pediatrics | Biotechnology | Thoracic surgery | Crosstalk | Lung cancer | Thymidine | Biochemistry | Metastasis | Kinases | Drug resistance | Cancer therapies | Cell adhesion & migration | Interleukin 6 | Angiogenesis | Cell growth | Rodents | Heme | NRF2 protein | Interleukin 8 | Squamous cell carcinoma | Small cell lung carcinoma | Cytokines | Heme oxygenase (decyclizing) | Non-small cell lung carcinoma | Lung carcinoma | Inflammation | Biophysics | Phosphorylase | Endothelial cells | Endothelium | Oxygenase | Chemotherapy | Plasmids | Medical prognosis | Polish Americans | Oxygenation | Cell migration | Tumors | Cancer | Endothelial Cells | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Life Sciences | Thymidine Phosphorylase | NF-E2-Related Factor 2 | Heme Oxygenase-1
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0158587
Reversine, an A3 adenosine receptor antagonist, has been shown to induce differentiated myogenic-lineage committed cells to become multipotent mesenchymal progenitor cells... 
OVEREXPRESSION | AMPLIFICATION | MULTIDISCIPLINARY SCIENCES | RESISTANCE | MITOTIC KINASE | AURORA KINASE | ANTITUMOR-ACTIVITY | INHIBITOR | EXPRESSION | CARCINOMA | ERLOTINIB | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | A549 Cells | Polyploidy | Apoptosis - drug effects | Carcinoma, Non-Small-Cell Lung - genetics | Purines - pharmacology | Giant Cells - drug effects | Giant Cells - metabolism | Humans | Lung Neoplasms - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Morpholines - pharmacology | Lung Neoplasms - pathology | Autophagy - drug effects | Blotting, Western | Dose-Response Relationship, Drug | Autophagosomes - drug effects | Caspases - metabolism | Flow Cytometry | Time Factors | Cell Line, Tumor | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Complications and side effects | Autophagy (Cytology) | Care and treatment | Analysis | Lung cancer | Research | Apoptosis | Cell proliferation | Mesenchyme | Leukemia | Dosage | Kinases | Autophagy | Anticancer properties | Cell growth | Medical laboratories | Cell cycle | Life sciences | Medical research | Medical technology | Non-small cell lung carcinoma | Caspase | Pharmacology | Breast cancer | Radiation therapy | Chemical compounds | Progenitor cells | Hospitals | Stem cells | Cells (biology) | Phagocytosis | Cancer | Tumors
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2017, Volume 12, Issue 4, p. e0174241
Journal Article
The Journal of clinical investigation, ISSN 1558-8238, 2019, Volume 129, Issue 3, pp. 1211 - 1228
...) polymerase inhibitors (PARPi) selectively target cancer cells with DNA repair deficiencies such as those caused by BRCA1 mutations or ERCC1 defects... 
BREAST-CANCER | MEDICINE, RESEARCH & EXPERIMENTAL | REPAIR | THERAPY | IMMUNOTHERAPY | DNA-DAMAGE RESPONSE | PD-L1 EXPRESSION | MUTATIONAL LANDSCAPE | SENSITIVITY | BLOCKADE | LYMPHOCYTES | Endonucleases - deficiency | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Endonucleases - metabolism | Interferon-gamma - metabolism | Triple Negative Breast Neoplasms - drug therapy | DNA-Binding Proteins - deficiency | DNA-Binding Proteins - metabolism | BRCA1 Protein - metabolism | Triple Negative Breast Neoplasms - pathology | Female | Membrane Proteins - metabolism | Interferon-gamma - genetics | Nucleotidyltransferases - metabolism | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | A549 Cells | Carcinoma, Non-Small-Cell Lung - genetics | Membrane Proteins - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Poly (ADP-Ribose) Polymerase-1 - metabolism | B7-H1 Antigen - genetics | BRCA1 Protein - genetics | Poly(ADP-ribose) Polymerase Inhibitors - pharmacology | B7-H1 Antigen - metabolism | Triple Negative Breast Neoplasms - genetics | Triple Negative Breast Neoplasms - metabolism | Nucleotidyltransferases - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Poly (ADP-Ribose) Polymerase-1 - genetics | Enzyme inhibitors | Cellular immunity | Dosage and administration | Genetic aspects | Research | Gene expression | Lung cancer, Non-small cell | Drug therapy | Chromatin | DNA damage | Lung cancer | Poly(ADP-ribose) | Genomes | Mitochondrial DNA | Cancer therapies | DNA repair | Defects | Metastases | Ovarian cancer | Ribose | Lymphocytes | Immunotherapy | Cyclic GMP | Cell cycle | Sensors | Deoxyribonucleic acid--DNA | Phenotypes | Immune response | AMP | BRCA1 protein | Immunomodulation | Tumor cells | Non-small cell lung carcinoma | Poly(ADP-ribose) polymerase | Breast cancer | Patients | Poly(ADP-ribose) Polymerase 1 | Chemotherapy | Medical prognosis | Micronuclei | PD-L1 protein | ERCC1 protein | Interferon | Mutation | Tumors
Journal Article
PloS one, ISSN 1932-6203, 2016, Volume 11, Issue 10, p. e0165225
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e66931
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2017, Volume 12, Issue 9, p. e0185021
Background Chemotherapy insensitivity continues to pose significant challenges for treating non-small cell lung cancer (NSCLC... 
CANCER-CELLS | MATRIX METALLOPROTEINASES | INVASION | ACTIVATED PROTEIN-KINASE | AKT OVEREXPRESSION | MULTIDISCIPLINARY SCIENCES | TUMOR | PROLIFERATION | PI3K/AKT SIGNALING PATHWAY | INHIBITORS | DENBINOBIN | A549 Cells | Lung Neoplasms - drug therapy | Phenanthrenes - therapeutic use | Humans | Caspase 3 - metabolism | Antineoplastic Agents - therapeutic use | Mitochondria - drug effects | Adenocarcinoma - drug therapy | Blotting, Western | Cell Movement - drug effects | Matrix Metalloproteinase 9 - metabolism | Cell Line, Tumor | Cell Proliferation - drug effects | Molecular Docking Simulation | Carcinoma, Non-Small-Cell Lung - drug therapy | Antimitotic agents | Care and treatment | Physiological aspects | Research | Antineoplastic agents | Lung cancer, Non-small cell | Apoptosis | Adenocarcinoma | Leukocyte migration | Lung cancer | Cytotoxicity | AKT protein | Metastasis | Assaying | Caspase-3 | Cancer therapies | Molecular docking | Proteins | Mitochondria | Cell growth | Enzymatic activity | Inhibition | Catalysis | Outdoor air quality | Immunoglobulins | Phenanthrene | Wound healing | AMP | Iodides | Gene expression | 1-Phosphatidylinositol 3-kinase | Studies | Chemotherapy | Pharmacy | Cell migration | Biotechnology | Flow cytometry | Enzyme activity | Colorimetry | Activation | Matrix metalloproteinase | Kinases | AMP-activated protein kinase | Western blotting | Cell cycle | Metalloproteinase | Incubation | Research & development--R&D | Molecular interactions | Caspase | Non-small cell lung carcinoma | Gelatinase | Gelatinase B | Gelatinase A | Cytometry | Air pollution | Annexin V | Alzheimers disease | Research & development | R&D
Journal Article
Oncogene, ISSN 1476-5594, 2018, Volume 37, Issue 36, pp. 5007 - 5019
Journal Article